1. Medtech Insight
  2. >>Device Area

AAOS: Study Finds Robots Do Not Help Knee Revisions; Analysts Bullish On Ortho; More

 
• By Reed Miller and Marion Webb

Studies presented at the American Academy of Orthopedic Surgeons' annual meeting in San Francisco found that robotics did not improve revision rates in total knee arthroplasty surgeries and chatbots do not consistently provide accurate information to orthopedics patients. Wall Street analysts came away from the meeting bullish on the joint reconstruction surgery market. More news from the 12-16 February meeting.

San Francisco, California, USA Noe Valley skyline.
• Source: Shutterstock

Robotic-assisted cementless total knee arthroplasty (TKA) does not improve revision rates two years following surgery compared to standard TKA, according to a new registry analysis presented at the American Academy of Orthopedic Surgeons conference in San Francisco.

Researchers led by Emily Jimenez, a data scientist at AAOS, and Lucas Nikkel, an orthopedic surgeon at Johns Hopkins University, analyzed the American Joint Replacement Registry (AJRR) to compare...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Orthopedics

More from Device Area

Pathogen Sharing System Part Of Global Pandemic Agreement

 
• By Neena Brizmohun

Now that the landmark Pandemic Agreement has finally been adopted, work will start on drafting a pathogen access and benefit sharing system that will be voluntary for use by drug companies.

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.